U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
174781174781Pulmonary Resistance in Fontan Who Have Undergone Heart TransplantationTerminatedNo Results AvailableCongenital Disordershttps://ClinicalTrials.gov/show/NCT00268047
174782174782Left Ventricular Aneurysms in ChildrenTerminatedNo Results AvailableCongenital Disordershttps://ClinicalTrials.gov/show/NCT00268034
174783174783Automated Cardioverter Defibrillator in ChildrenCompletedNo Results AvailableCongenital Disordershttps://ClinicalTrials.gov/show/NCT00268021
174784174784Children and Adolescents Receiving Mechanical and Prosthetic ValvesTerminatedNo Results AvailableCongenital Disordershttps://ClinicalTrials.gov/show/NCT00268008
174785174785Ross Aortic Valve Replacement PatientsTerminatedNo Results AvailableCongenital Disordershttps://ClinicalTrials.gov/show/NCT00267995
174786174786Radiofrequency Ablation of Ectopic Atrial TachycardiaTerminatedNo Results AvailableCongenital Disordershttps://ClinicalTrials.gov/show/NCT00267982
174787174787A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type PsoriasisCompletedHas ResultsPsoriasisDrug: ustekinumab|Drug: placebohttps://ClinicalTrials.gov/show/NCT00267969
174788174788An Effectiveness and Safety Study of CNTO 1275 in Patients With Active Psoriatic ArthritisCompletedHas ResultsPsoriatic ArthritisDrug: CNTO 1275 63 mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00267956
174789174789Open-label Follow-up Trial of Fixed Dose Combination of Telmisartan + Hydrochlorothiazide in Hypertensive PatientsCompletedNo Results AvailableHypertensionDrug: telmisartan 80 mg + hydrochlorothiazide 25 mghttps://ClinicalTrials.gov/show/NCT00267943
174790174790Study of RSD1235-SR for the Prevention of Atrial Fibrillation/Atrial Flutter RecurrenceCompletedNo Results AvailableAtrial FibrillationDrug: Vernakalant (oral)|Drug: Placebo comparatorhttps://ClinicalTrials.gov/show/NCT00267930
174791174791Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique.CompletedNo Results AvailablePulmonary Disease, Chronic Obstructive|AsthmaDevice: Berodual Respimat|Device: Berodual HFA-MDIhttps://ClinicalTrials.gov/show/NCT00267917
174792174792Reference Values for Plasma CatecholsRecruitingNo Results AvailableHealthy Volunteers|Normal Physiologyhttps://ClinicalTrials.gov/show/NCT00267904
174793174793Brain Changes in Adolescents While Imagining and Observing Aggressive BehaviorCompletedNo Results AvailableAggressive Behaviorhttps://ClinicalTrials.gov/show/NCT00267891
174794174794Chemotherapy and HAART to Treat AIDS-related Primary Brain LymphomaRecruitingNo Results AvailableLymphoma-AIDS-Related|Brain NeoplasmDrug: Methotrexate|Drug: Rituximab|Drug: Leucovorinhttps://ClinicalTrials.gov/show/NCT00267865
174795174795Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisOther: as clinical practicehttps://ClinicalTrials.gov/show/NCT00267852
174796174796Effect of Exercise on Risk-factors of Elderly WomenTerminatedNo Results AvailableAtrophyBehavioral: physical exercise, wellnesshttps://ClinicalTrials.gov/show/NCT00267839
174797174797Immunopharmacological Effects of Rituximab in Atopic DermatitisCompletedNo Results AvailableDermatitis, AtopicDrug: Rituximabhttps://ClinicalTrials.gov/show/NCT00267826
174798174798The Effects of Craving and Abstinence From Cigarettes on Brain Metabolism in SmokersCompletedNo Results AvailableNicotine DependenceDrug: Bupropion (Zyban)https://ClinicalTrials.gov/show/NCT00267813
174799174799Database of Interstitial Lung DiseasesActive, not recruitingNo Results AvailableInterstitial Lung Diseaseshttps://ClinicalTrials.gov/show/NCT00267800
174800174800Molecular Genetic and Pathological Studies of Anal TumorsRecruitingNo Results AvailableRectal Cancer|Colon Cancer|Colonic Neoplasms|Anal CancerOther: genetic analysishttps://ClinicalTrials.gov/show/NCT00267787
174801174801Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.)Active, not recruitingNo Results AvailableCoronary ArteriosclerosisDevice: Fractional flow reservehttps://ClinicalTrials.gov/show/NCT00267774
174802174802Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC)CompletedHas ResultsCarcinoma, Renal CellDrug: Sunitinib Malate Continuous Daily Dosing|Drug: Sunitinib Malate Schedule 4/2https://ClinicalTrials.gov/show/NCT00267748
174803174803Measuring Preferences for Childbirth After CesareanRecruitingNo Results AvailablePregnancyBehavioral: Use of Computerized Decision Aid on Childbirthhttps://ClinicalTrials.gov/show/NCT00267735
174804174804Visilizumab for Moderate to Severe Inflammatory, Nonstricturing, Nonpenetrating Crohn's DiseaseCompletedNo Results AvailableCrohn's DiseaseDrug: Visilizumabhttps://ClinicalTrials.gov/show/NCT00267722
174805174805Visilizumab for Treatment of Perianal Fistulas in Crohn's DiseaseCompletedNo Results AvailableCrohn's DiseaseDrug: Visilizumabhttps://ClinicalTrials.gov/show/NCT00267709
174806174806Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal CancerCompletedHas ResultsOvarian Cancer|Fallopian Tube Cancer|Peritoneal CancerDrug: Bevacizumab|Drug: Gemcitabine|Drug: Carboplatinhttps://ClinicalTrials.gov/show/NCT00267696
174807174807Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 DiabetesTerminatedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: insulin aspart|Drug: glibenclamidehttps://ClinicalTrials.gov/show/NCT00267683
174808174808Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASHCompletedHas ResultsNonalcoholic Steatohepatitis|Liver DiseasesDrug: Pentoxifylline|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00267670
174809174809A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1Active, not recruitingNo Results AvailableAmphetamine-Related DisordersDrug: Reserpinehttps://ClinicalTrials.gov/show/NCT00267657
174810174810Ultrasound of the Inferior Vena Cava (IVC) and Dehydration Status in Pediatric Emergency PatientsCompletedHas ResultsDehydrationhttps://ClinicalTrials.gov/show/NCT00267644

* Görseller ve İçerik tekif hakkına sahip olabilir